Agentix Corp. SEC filings AGTX

Agentix Corp. has 153 filings in SEC EDGAR's recent list, going back to Apr 1, 2014. Its latest annual report, Form 10-K, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 14, 2022 (officer or director change). The company's fiscal year ends on March 31.

Form Description Filed Period
10-K Annual report Jul 1, 2026 Mar 31, 2026
10-K Annual report Jul 16, 2025 Mar 31, 2025
10-K Annual report Aug 30, 2024 Mar 31, 2024
10-K Annual report Jul 14, 2023 Mar 31, 2023
10-KT Transition report Jul 18, 2022 Mar 31, 2022
10-K Annual report Oct 7, 2021 Aug 31, 2021
10-K Annual report Dec 9, 2020 Aug 31, 2020
10-K/A Amended annual report Nov 23, 2020 Aug 31, 2019
10-K Annual report Dec 5, 2019 Aug 31, 2019
10-K Annual report Nov 13, 2018 Aug 31, 2018
10-K Annual report Dec 18, 2017 Aug 31, 2017
10-K Annual report Dec 12, 2016 Aug 31, 2016
10-K Annual report Dec 16, 2015 Aug 31, 2015

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
AGTX (OTC)
Fiscal year ends
March 31
Incorporated in
NV
Headquarters
Dana Point, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1603345
Former names
FairWind Energy Inc. (until Jun 27, 2019)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.